Novartis to Add Radioligand Therapy Manufacturing Facility in Winter Park, Florida, Fourth in U.S. to Serve Patients & Advance $23 Billion Investment
January 10, 2026
January 10, 2026
BASEL, Switzerland, Jan. 10 -- Novartis, a pharmaceutical company, issued the following news release:
* * *
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
* New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
* Purpose-built facility will strengthen Nov . . .
* * *
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
* New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
* Purpose-built facility will strengthen Nov . . .